Bionano Genomics, Inc. (BNGO)
USD 4.05
(1.25%)
USD 4.05
(1.25%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -232.49 Million USD | -75.34% |
| 2022 | -132.59 Million USD | -83.06% |
| 2021 | -72.43 Million USD | -76.09% |
| 2020 | -41.13 Million USD | -37.87% |
| 2019 | -29.83 Million USD | -61.31% |
| 2018 | -18.49 Million USD | 20.84% |
| 2017 | -23.36 Million USD | -23.96% |
| 2016 | -18.84 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -16.22 Million USD | 48.37% |
| 2024 Q1 | -31.42 Million USD | 28.41% |
| 2023 Q3 | -112.56 Million USD | -189.28% |
| 2023 FY | -232.49 Million USD | -75.34% |
| 2023 Q4 | -43.89 Million USD | 61.01% |
| 2023 Q1 | -37.12 Million USD | 4.02% |
| 2023 Q2 | -38.91 Million USD | -4.82% |
| 2022 Q4 | -38.67 Million USD | -21.59% |
| 2022 Q1 | -29.95 Million USD | -30.52% |
| 2022 Q3 | -31.8 Million USD | 1.09% |
| 2022 FY | -132.59 Million USD | -83.06% |
| 2022 Q2 | -32.15 Million USD | -7.37% |
| 2021 Q3 | -20.75 Million USD | -10.47% |
| 2021 Q4 | -22.94 Million USD | -10.58% |
| 2021 FY | -72.43 Million USD | -76.09% |
| 2021 Q1 | -9.94 Million USD | 15.2% |
| 2021 Q2 | -18.78 Million USD | -88.86% |
| 2020 FY | -41.13 Million USD | -37.87% |
| 2020 Q1 | -10.51 Million USD | -33.03% |
| 2020 Q2 | -8.07 Million USD | 23.18% |
| 2020 Q3 | -10.79 Million USD | -33.66% |
| 2020 Q4 | -11.73 Million USD | -8.7% |
| 2019 FY | -29.83 Million USD | -61.31% |
| 2019 Q4 | -7.9 Million USD | -23.48% |
| 2019 Q3 | -6.39 Million USD | 16.52% |
| 2019 Q2 | -7.66 Million USD | 2.38% |
| 2019 Q1 | -7.85 Million USD | -22.46% |
| 2018 Q1 | -3.84 Million USD | 35.01% |
| 2018 Q2 | -3.31 Million USD | 13.93% |
| 2018 FY | -18.49 Million USD | 20.84% |
| 2018 Q3 | -4.92 Million USD | -48.76% |
| 2018 Q4 | -6.41 Million USD | -30.15% |
| 2017 FY | -23.36 Million USD | -23.96% |
| 2017 Q1 | -5.68 Million USD | 0.0% |
| 2017 Q2 | -6.67 Million USD | -17.39% |
| 2017 Q3 | -5.08 Million USD | 23.81% |
| 2017 Q4 | -5.91 Million USD | -16.41% |
| 2016 FY | -18.84 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -88.48 Million USD | -162.76% |
| Biodesix, Inc. | -52.14 Million USD | -345.85% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -2829.226% |
| Castle Biosciences, Inc. | -57.46 Million USD | -304.575% |
| DarioHealth Corp. | -59.42 Million USD | -291.225% |
| Exact Sciences Corporation | -204.14 Million USD | -13.884% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 127.513% |
| Illumina, Inc. | -1.16 Billion USD | 79.975% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | -2189.047% |
| iSpecimen Inc. | -11.09 Million USD | -1994.628% |
| Standard BioTools Inc. | -74.65 Million USD | -211.419% |
| 23andMe Holding Co. | -666.7 Million USD | 65.128% |
| Medpace Holdings, Inc. | 282.81 Million USD | 182.208% |
| NeoGenomics, Inc. | -87.96 Million USD | -164.293% |
| Inotiv, Inc. | -105.14 Million USD | -121.127% |
| Psychemedics Corporation | -4.15 Million USD | -5496.846% |
| Prenetics Global Limited | -62.72 Million USD | -270.661% |
| Precipio, Inc. | -5.85 Million USD | -3872.202% |
| RadNet, Inc. | 3.04 Million USD | 7737.746% |
| Sotera Health Company | 51.37 Million USD | 552.532% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -14918.928% |
| Exagen Inc. | -23.68 Million USD | -881.439% |
| Natera, Inc. | -434.8 Million USD | 46.529% |
| Aspira Women's Health Inc. | -16.69 Million USD | -1293.008% |
| Neogen Corporation | -9.42 Million USD | -2367.817% |
| Myriad Genetics, Inc. | -112 Million USD | -107.583% |
| ICON Public Limited Company | 612.33 Million USD | 137.968% |
| CareDx, Inc | -190.28 Million USD | -22.182% |
| Check-Cap Ltd. | -17.56 Million USD | -1223.389% |
| Twist Bioscience Corporation | -208.72 Million USD | -11.387% |
| Guardant Health, Inc. | -479.44 Million USD | 51.508% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -8743.256% |
| Fulgent Genetics, Inc. | -167.82 Million USD | -38.533% |
| Sera Prognostics, Inc. | -36.24 Million USD | -541.502% |
| OPKO Health, Inc. | -188.86 Million USD | -23.101% |
| Personalis, Inc. | -108.29 Million USD | -114.683% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | -2237.304% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -14918.928% |
| MDxHealth SA | -43.1 Million USD | -439.427% |
| Prenetics Global Limited | -62.72 Million USD | -270.661% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | -2211.006% |
| Mainz Biomed B.V. | -26.29 Million USD | -784.147% |
| Trinity Biotech plc | -24.01 Million USD | -867.995% |
| Neuronetics, Inc. | -30.18 Million USD | -670.125% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -2829.226% |